We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The second-generation sulfonylureas: change or progress?
- Authors
Kreisberg, Robert A.; Kreisberg, R A
- Abstract
Editorial. Presents information on second-generation sulfonylurea agents, glipizide and glyburide, which have been approved by the U.S. Food and Drug Administration for the treatment of patients with type II or non-insulin-dependent diabetes mellitus. Results of comparative studies of glipizide, glyburide and chlorpropamide; Differences between the first generation and second-generation sulfonylureas; Role played by sulfonylureas in the treatment of diabetic patients.
- Subjects
TREATMENT of diabetes; DRUGS; HYPOGLYCEMIC agents; TYPE 2 diabetes; SULFONYLUREAS; THERAPEUTICS
- Publication
Annals of Internal Medicine, 1985, Vol 102, Issue 1, p125
- ISSN
0003-4819
- Publication type
editorial
- DOI
10.7326/0003-4819-102-1-125